Retrobulbar irradiation for thyroid-associated orbitopathy: Double-blind comparison between 2.4 and 16 Gy

International Journal of Radiation Oncology Biology Physics

Volumn 55, Issue 1, 2003, Pages 182-189

  Gerling, Jürgen ^a   Kommerell, Guntram ^a   Henne, Karl ^a   Laubenberger, Jörg ^a   Schulte Mönting, Jürgen ^a   Fells, Peter ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

Graves' ophthalmopathy; Orbit; Radiotherapy; Thyroid associated orbitopathy

Indexed keywords

DISEASES; DOSIMETRY; EYE MOVEMENTS; IRRADIATION; MUSCLE; PATIENT TREATMENT; RADIATION;

RETROBULBAR IRRADIATION;

ONCOLOGY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRAOCULAR MUSCLE; EYE MOVEMENT; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT DISEASE; OUTCOMES RESEARCH; PHOTOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; THICKNESS; THYROID DISEASE; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; GRAVES DISEASE; HUMANS; MALE; MIDDLE AGED; ORBITAL DISEASES; RADIOTHERAPY DOSAGE;

EID: 0037216283     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)03795-1     Document Type: Article

References (59)

1. Juler F.A. Acute purulent keratitis in exophthalmic goiter treated by repeated tarsorrhaphy resection of cervical sympathetics and x-rays Retention of vision in one eye . Trans Ophthalmol Soc UK. 33:1913;58-62.
2. Jones A. Orbital x-ray therapy of progressive exophthalmos. Br J Radiol. 24:1951;637-646.
3. Mandeville F.B. Roentgen therapy of orbital-pituitary portals for progressive exophthalmos following subtotal thyroidectomy. Radiology. 41:1943;268-271.
4. Woloschak G.E., Chang-Liu C.M. Differential modulation of specific gene expression following high and low radiations. Radiat Res. 124:1990;183-187.
5. Rodemann H.P., Peterson H.P., Schwenke K., et al. Terminal differentiation of human fibroblasts is induced by radiation. Scan Microsc. 5:1992;1135-1143.
6. Rodemann H.P., Bamberg M. Cellular basis of radiation-induced fibrosis. Radiother Oncol. 35:1995;83-90.
7. Teng C.S., Crombie A.L., Hall R., Ross W.M. An evaluation of supervoltage orbital irradiation for Graves' ophthalmopathy. Clin Endocrinol (Oxf). 13:1980;545-551.
8. Brennan M.W., Leone C.R., Janaki L. Radiation therapy for Graves' disease. Am J Ophthalmol. 96:1983;195-199.
9. Olivotto I.A., Ludgate C.M., Allen L.H., et al. Supervoltage radiotherapy for Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys. 11:1985;2085-2090.
10. Konishi J., Iida Y., Kasagi K., et al. Clinical evaluation of radiotherapy for Graves' ophthalmopathy. Endocrinol Jpn. 33:1986;637-645.
11. Harteman P., Leclere J., Bey P., et al. Le traitement des ophthalmopathies thyroidiennes par la radiothérapie orbitaire externe. Ann Endocrinol (Paris). 47:1986;389-395.
12. Marcocci C., Bartalena L., Panicucci M., et al. Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy A comparative study . Clin Endocrinol. 27:1987;33-42.
13. Bartalena L., Marcocci C., Panicucci M., et al. Orbital irradiation in the treatment of Graves' ophthalmopathy. Bull Soc Belge Ophthalmol. 226:1988;71-83.
14. Kriss J.P., Petersen I.A., Donaldson S.S., et al. Supervoltage orbital radiotherapy for progressive Graves' ophthalmopathy Results of a twenty-year experience . Acta Endocrinol (Copenh). 121:1989;154-159.
15. Sandler H.M., Rubenstein J.H., Fowble B.L., et al. Results of radiotherapy for thyroid ophthalmopathy. Int J Radiat Oncol Biol Phys. 17:1989;823-827.
16. Petersen I.A., Kriss J.P., McDougall I.R., et al. Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys. 19:1990;259-264.
17. Marcocci C., Bartalena L., Bogazzi F., et al. Role of orbital radiotherapy in the treatment of Graves' ophthalmopathy. Exp Clin Endocrinol. 97:1991;332-337.
18. Fells P. Thyroid-associated eye disease Clinical management . Lancet. 338:1991;29-32.
19. Lloyd W.C., Leone C.R. Supervoltage orbital radiotherapy in 36 cases of Graves' disease. Am J Ophthalmol. 113:1992;374-380.
20. Donaldson S.S., Bagshaw M.A., Kriss J.P. Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab. 37:1973;276-285.
21. Wildmeister W., Horster F.A. Zur Therapie der endokrinen Ophthamopathie. Dtsch Med Wschr. 97:1972;1708-1711.
22. Heinze H.G., Pickardt C.R., Brand H. Strahlentherapie der endokrinen Ophthalmopathie mit 18 MeV-Bremsstrahlung. Strahlentherapie. 148:1974;226-234.
23. Grauthoff H., Wuttke H., Frommhold H. Zur Strahlentherapie der endokrinen Orbitopathie. Strahlentherapie. 156:1980;469-474.
24. Uhlenbrock D., Fischer H.J., Rohwerder R. Strahlentherapie der endokrinen Ophthalmopathie - Auswertung von 56 Fällen. Strahlentherapie. 160:1984;485-491.
25. von Graefe A. Bemerkungen über Exophthalmus mit Struma und Herzleiden. Arch Ophthalmol. 3:1857;278.
26. Hutchinson J. Introductory remarks on Graves' disease. In Special meeting for the collection of facts as to Graves' disease . Trans Ophthalmol Soc UK. 6:1886;25.
27. Reynolds R.J. A contribution to the clinical history of Graves' disease (exophthalmic goitre). Lancet. 1:1890;1055.
28. Prirbam A. Zur Prognose des Morbus Basedowii. Prager Med Wochenschr. 46:1895;521.
29. Williamson R.T. Remarks on prognosis in exophthalmic goitre. BMJ. 2:1896;1373.
30. Clarke J.F. The etiology, prognosis and treatment of exophthalmic goitre. Am J Ophthalmol. 11:1897;349.
31. Murray G.R. The clinical history and symptoms of hundred and twenty cases of exophthalmic goitre. Trans R Med Chir Soc. 86:1902;141.
32. Mackenzie H. A lecture on Graves' disease. BMJ. 2:1905;1077.
33. Eulenberg A. Umfrage über die Behandlung des Morbus Basedowii. Medizinische Klinik. 2:1908;57.
34. Baker A.R. Exophthalmic goiter. Ophthalmology. 5:1908;219.
35. Jackson J.M., Mead L.G. Some clinical observations on the diagnosis and treatment of exophthalmic goitre. Boston Med Surg J. 158:1908;346.
36. Syllaba L. Über die Prognose bei der Basedow'schen Krankheit. Wiener Med Blätter. 28:1909;323.
37. Hales I.B., Rundle F.F. Ocular changes on Graves' disease A long term follow-up study . Q J Med. 29:1960;113-126.
38. Perros P., Cromble A., Kendall-Taylor P. Natural history of thyroid associated ophthalmopathy. Clin Endocrinol. 42:1995;45-50.
39. Kao S.C.S., Kendler D.L., Nugent R.A., et al. Radiotherapy in the management of thyroid orbitopathy. Arch Ophthalmol. 111:1993;819-823.
40. Mourits M.P., van Kempen-Harteveld M.L., Garcia M.B., et al. Radiotherapy for Graves' orbitopathy Randomised placebo-controlled study . Lancet. 355:2000;1505-1509.
41. Gorman C.A., Garrity J.A., Fatourechi V., et al. A prospective, randomized, double-blind placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology. 108:2001;1523-1534.
42. Kahaly G.J., Rösler H.P., Pitz S., et al. Low- versus high-dose radiotherapy for Graves' ophthalmopathy A randomized, single blind trial . J Clin Endocrinol Metabol. 85:2000;102-108.
43. Classification of eye changes of Graves' disease. Thyroid. 2:1992;235-236.
44. Gorman C.A. Clever is not enough NO SPECS is form in search of function . Thyroid. 1:1991;353-355.
45. Gerling J., Lieb B., Kommerell G. Duction ranges in normals and patients with Graves' ophthalmopathy, determined with the Goldmann perimeter. Int Ophthalmol. 21:1998;213-221.
46. Price D.D., Bush F.M., Long S., et al. A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales. Pain. 56:1994;217-226.
47. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 6:1979;65-70.
48. Haux R., Schumacher M., Weckesser G. Rank tests for complete block designs. Biom J. 5:1984;567-582.
49. Duke-Elder S., MacFaul P.A. System of ophthalmology. 14:1972;981 Henry Kimpton Publishers, London.
50. Merriam G.R. Jr, Szechter A., Focht E.F. The effects of ionizing radiations on the eye. Front Radiat Ther Oncol. 6:1972;346-385.
51. Jiang G.L., Tucker S.L., Guttenberger R., et al. Radiation-induced injury to the visual pathway. Radiother Oncol. 30:1994;17-25.
52. Kinyoun J.L., Kelina R.E., Brower S.A., et al. Radiation retinopathy after orbital irradiation for Graves' ophthalmopathy. Arch Ophthalmol. 102:1984;1473-1476.
53. Elsas T., Thorud E., Jetne V., et al. Retinopathy after low dose irradiation for an intracranial tumor of the frontal lobe. Acta Ophthalmol. 66:1988;65-68.
54. Nikoskelainen E., Joensuu H. Retinopathy after irradiation for Graves' ophthalmopathy. Lancet. 2:1989;690-691.
55. Lopez P.F., Sternberg P. Jr, Dabbs C.K., et al. Bone marrow transplant retinopathy. Am J Ophthalmol. 112:1991;635-646.
56. Miller M.L., Goldberg S.H., Bullock J.D. Radiation retinopathy after standard radiotherapy for thyroid-related ophthalmopathy. Am J Ophthalmol. 112:1991;600-601.
57. Nygaard B., Specht L. Transitory blindness after retrobulbar irradiation of Graves' ophthalmopathy. Lancet. 351:1998;725-726.
58. Snijders-Keilholz A., De Keizer R.J., Goslings B.M., et al. Probable risk of tumour induction after retro-orbital irradiation for Graves' ophthalmopathy. Radiother Oncol. 38:1996;69-71.
59. Yudkin P.L., Stratton I.M. How to deal with regression to the mean in intervention studies. Lancet. 347:1996;241-243.